← Eichor
Condition: Dry Mouth Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dry Mouth

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06771427Application of Neuro-electrostimulation as a Treatment for Patients With Dry Mouth
NA · 1 location(s) · Universidad Autonoma del Estado de Mexico · NCT07593495A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RE
Phase 2 · 6 location(s) · Lubris Bio Pty Ltd · NCT07118241Ultra-High Frequency Ultrasonography in Sjögren's Syndrome
NA · 1 location(s) · University of Pisa · NCT06338735Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Phase 2 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT07281456Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease
NA · 1 location(s) · Universidade da Coruña · NCT07588191Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4 · 1 location(s) · Peking Union Medical College Hospital · NCT06410833Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 · 28 location(s) · Vor Biopharma · NCT07404865A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous
Phase 1/Phase 2 · 1 location(s) · West China Hospital · NCT07035626A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Phase 1 · 19 location(s) · GlaxoSmithKline · NCT07371468Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06428188Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
Phase 1/Phase 2 · 4 location(s) · RiboX Therapeutics Ltd. · NCT06714253Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye
Phase 1 · 1 location(s) · Iran University of Medical Sciences · NCT06543667The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Phase 4 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04981145Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT06392711The Pathogenesis and Natural History of Sjogren's Disease
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT01425892A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Phase 3 · 174 location(s) · Amgen · NCT06747949Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT
NA · 1 location(s) · Tzu Chi University · NCT07711626Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Phase N/A · 1 location(s) · Duke University · NCT03276923d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
Phase 1 · 1 location(s) · Stanford University · NCT04392622An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
NA · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06379646Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
NA · 1 location(s) · Terry L. Wahls · NCT07180537Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Diseas
Phase N/A · 1 location(s) · Hospital Universitario Araba · NCT07249060Rheumatology Patient Registry and Biorepository
Phase N/A · 1 location(s) · Yale University · NCT04402086Screening of Biomarkers and Related Mechanisms for RIX
Phase N/A · 4 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07170358Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT06842316Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related
NA · 1 location(s) · ZAINAB MAT YUDIN · NCT06984848B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
NA · 1 location(s) · University Hospital, Brest · NCT04931160
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.